Popular weight-loss drugs, especially tirzepatide, are linked to modestly lower CPAP initiation among adults with Type 2 diabetes and obstructive sleep apnea (OSA), according to a research letter in ...
Researchers at Ottawa Hospital Research Institute and University of Ottawa found that high risk of obstructive sleep apnea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback